Clinical study of ileal bile acid transporter inhibitor on changes in bowel movements and various metabolic markers in type 2 diabetic patients
Not Applicable
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000045508
- Lead Sponsor
- Kurume University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnant or lactating women Patient with intestinal obstruction due to tumor or hernia etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bowel movements (frequency of bowel movements, Bristol Scale)
- Secondary Outcome Measures
Name Time Method Blood glucose,HbA1c,LDL,HDL,triglyceride,fatty acid fraction,AST,ALT,gammaGTP,Total bile acid,TSH,FT3,FT4,CRP,UA, Ferritin,body weight